JK
Insider
John Kiely
DirectorJohn Kiely (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Amneal Pharmaceuticals, Inc. (AMRX). The largest single filing was $882K of AMRX (50,000 sh × $17.64, as filed), executed Aug 13.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$882K
shares × price, as filed
Last traded
Aug 13
Filed Aug 14
Median ADV $37.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
AMRX
Amneal Pharmaceuticals, Inc.
AMRX · 0 buys · 4 sells
4 filings
Recent filings
AMRXSALE
Amneal Pharmaceuticals, Inc.
View filing →
$882K50,000 sh × $17.64
Exec Aug 13
Filed Aug 14 · 4:29 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. View filing → $295K
32,000 sh × $9.23
Exec Aug 27 2025
Filed Aug 28 2025 · 5:30 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. View filing → $380K
50,000 sh × $7.59
Exec May 12 2025
Filed May 13 2025 · 5:30 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. View filing → $143K
17,058 sh × $8.38
Exec Nov 22 2024
Filed Nov 26 2024 · 5:30 PM ET